Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
5 and 10 mg Donepezil are under final development using the oral dispersible RapidFilm® technology - easy to swallow as water is not needed More
5, 10 and 15 mg drug substance Olanzapine uses oral film dosage form dissolving within seconds without need of water More
We have technology to produce chiral intermediates of high quality by biotransformation More
2,5mg and 5mg Zolmitriptan Rapidfilm® uses oral dissolving film strip technology without need of water. More
Device and Process for Economical, Semi-Continuous Biodegradable Microsphere Production More
Related Reports
Market Research Reports provided by reports.innovaro.com
Sep 2010 - 12 pages - $99
Nov 2011 - 7 pages - $75
Jan 2011 - 12 pages - $99
Jan 2011 - 11 pages - $99
Dec 2010 - 11 pages - $99
Oct 2010 - 12 pages - $99
Dec 2010 - 14 pages - $99
Jan 2011 - 25 pages - $99
Oct 2010 - 23 pages - $99
Jul 2007 - $15,000
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us